Robert S. Kass, PhD

Departments And Divisions

  • Department of Pharmacology
  • Hosack Professor of Pharmacology
  • Alumni Professor of Pharmacology (in Neuroscience)
  • Chairman, Department of Pharmacology
Robert S. Kass, <span>PhD</span>

The focus of Dr. Kass' research program is the structure and function of ion channels that are expressed primarily in the heart. Dr. Kass has directed NIH and/or NSF sponsored research for thirty years that has contributed to our understanding of the fundamental cellular and molecular basis of cardiac electrical activity through a multidisciplinary approach bridging basic biophysical and clinical science.  Contributions from this work include the cellular basis of calcium-dependent arrhythmogenic activity in the heart, basic mechanisms of action of calcium channel blocking drugs, and the molecular events underlying the control of the duration of electrical events in the heart during sympathetic nerve stimulation.  More recently his laboratory has focused on understanding the molecular physiology and pharmacology of congenital arrhythmias. These arrhythmias are caused by inherited mutations in genes coding for ion channels and/or ion channel related proteins expressed in the heart. This work has contributed to an understanding of gene-specific risk factors caused by mutation-induced changes in heart ion channel activity, and to the development of a mutation-specific approach to manage these disorders. The mutation-specific therapeutic strategy, verified in genotyped patients, has established the principle that two variants of the same genetic disorder require dramatically different therapeutic strategies for disease management based on biophysical properties of specific genetic lesions. This approach has evolved from close collaborations with clinical colleagues in which information is shared from clinic to basic laboratory and back to clinic. Additional studies are aimed at unraveling the structural basis of mutation-induced, and potentially lethal, disease phenotypes using approaches such as voltage-clamp fluorometry to directly measure movement of gating machinery in the ion channel of interest as well as biochemical methods of directly probing structures of region of ion channels that are hotspots for disease-causing mutations and the use of computer-based modeling to understand both structure and functional consequences of these mutations. The goal of this approach is to unmask new and specific targets for the development of anti-arrhythmic drugs. Currently, work also is underway in the laboratory to study the mechanisms underlying heritable arrhythmias in the context of complex genetic backgrounds by investigating the cellular electrophysiology of cardiomyocytes differentiated from inducible pluripotent stem cells derived from family members of patients harboring disease-causing mutations.  This approach offers, for the first time, opportunities to screen drugs for effective disease management when multiple genes may be involved in the disease phenotype.

Lab Locations

Research Interests

  • Biophysics/Ion Channels
  • Cellular/Molecular/Developmental Neuroscience

Publications

 

Bankston, J.B., Sampson, K.J., Kateriya, S., I.W. Glaaser, D.L. Malito, W. Chung, and R.S. Kass. (2007).  A novel LQT-3 mutation disrupts an inactivation gate complex with distinct rate-dependent phenotypic consequences.  Channels 1:4, 273-280.

Chen L, Marquardt ML, Tester DJ, Sampson KJ, Ackerman MJ, Kass RS.(2007) Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc Natl Acad Sci U S A. Dec 26;104(52):20990-5. Epub 2007 Dec 19.

Bankston JR, Yue M, Chung W, Spyres M, Pass RH, Silver E, Sampson KJ, Kass RS.,  (2007) A Novel and Lethal De Novo LQT-3 Mutation in a Newborn with Distinct Molecular Pharmacology and Therapeutic Response. PLoS ONE. Dec 5;2(12):e1258.

Sampson KJ, Terrenoire C, Cervantes DO, Kaba RA, Peters NS & Kass RS. (2008). Adrenergic regulation of a key cardiac potassium channel can contribute to atrial fibrillation: evidence from an IKs transgenic mouse. J Physiol 586, 627-637

Chung DY, Chan PJ, Bankston JR, Yang L, Liu G, Marx SO, Karlin A & Kass RS. (2009). Location of KCNE1 relative to KCNQ1 in the I(KS) potassium channel by disulfide cross-linking of substituted cysteines. Proc Natl Acad Sci U S A 106, 743-748.

Kurokawa J, Bankston JR, Kaihara A, Chen L, Furukawa T & Kass RS. (2009). KCNE variants reveal a critical role of the beta subunit carboxyl terminus in PKA-dependent regulation of the IKs potassium channel. Channels (Austin) 3, 16-24.

Lindegger N, Hagen BM, Marks AR, Lederer WJ & Kass RS. (2009). Diastolic transient inward current in long QT syndrome type 3 is caused by Ca2+ overload and inhibited by ranolazine. J Mol Cell Cardiol 47, 326-334.

Terrenoire C, Houslay MD, Baillie GS & Kass RS. (2009). The cardiac IKs potassium channel macromolecular complex includes the phosphodiesterase PDE4D3. J Biol Chem 284, 9140-9146.

Bankston JR & Kass RS. (2010). Molecular determinants of local anesthetic action of beta-blocking drugs: Implications for therapeutic management of long QT syndrome variant 3. J Mol Cell Cardiol 48, 246-253.

Sampson KJ, Iyer V, Marks AR & Kass RS. (2010). A computational model of Purkinje fibre single cell electrophysiology: Implications for the Long QT syndrome. J Physiol